** Shares of Compumedics CMP.AX fall 5% to A$0.285, their biggest intraday pct loss since May 6
** The medical device maker lowers its revenue forecast for FY26 to a range of A$50 million ($32.20 million)- A$55 million, compared to its previous outlook of A$55 million
** Also sees FY26 EBITDA of about A$3 million, lower than earlier forecast of A$5 million
** Co attributes lowered guidance to the lag between reported revenues and sales orders taken for its Somfit device
** YTD, shares up 7.6%
($1 = 1.5528 Australian dollars)
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。